Alliance for Childrenās Therapeutics Expands Research to Include MS
The Alliance for Childrenās TherapeuticsĀ recently announced its plans to broaden its scope of research programs to include several diseases, namely, inflammatory bowel disease (IBD), asthma, and multiple sclerosis (MS) ā a progressive, neurodegenerative disease that is estimated to affect 300,000 to 400,000 adults…